Advanced in Chondrosarcoma

Kenji Kondo

Otorhinolaryngology And Head And Neck Surgery, 
Tokyo, JP 
Advanced in Chondrosarcoma
Otorhinolaryngology And Head And Neck Surgery, 
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Kenji Kondo practices in Tokyo, Japan. Mr. Kondo is rated as an Advanced expert by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Bell's Palsy, Facial Paralysis, Anosmia, Endoscopy, and Endoscopic Transnasal Transsphenoidal Surgery.

His clinical research consists of co-authoring 247 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Chondrosarcoma.

Gender
Male

Locations

Otorhinolaryngology And Head And Neck Surgery, Tokyo, Japan
Other Locations
Department Of Otolaryngology And Head And Neck Surgery, 7-3-1, Bunkyo Ku, Hongo, 1138655, Japan
Department Of Otolaryngology And Head And Neck Surgery, Bunkyo, Japan
Tokushima, 7700812, Japan
Minato, 1088639, Japan
Yokohama, 2408501, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

247 Total Publications

Definite Vestibular Paroxysmia Comorbid With Definite Ménière's Disease: A Rare Case Highlighting Diagnostic and Therapeutic Implications.
Definite Vestibular Paroxysmia Comorbid With Definite Ménière's Disease: A Rare Case Highlighting Diagnostic and Therapeutic Implications.
Journal: Cureus
Published: September 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kondo's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 55 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile